Skip to main content

Table 1 Patient characteristics

From: The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer

  

n= 102

%

Tumor

 

T1

66

64.7

 

T2

27

26.5

 

T3

6

5.9

 

T4

3

2.9

Nodus

 

Negative

58

56.9

 

Positive

42

41.2

 

Unknown

2

1.9

Grade

   
 

I

30

29.4

 

II

35

34.3

 

III

37

36.3

Estrogen receptor (ER)

 

Negative

24

23.5

 

Positive

78

76.5

Progesterone receptor (PR)

 

Negative

35

34.3

 

Positive

67

65.7

HER2

 

Negative

84

82.4

 

Positive

18

17.6

Ki67

 

Negative

21

20.6

 

+

37

36.3

 

++

20

19.6

 

+++

24

23.5

Adjuvant treatment

 

Chemotherapy

35

34.3

 

Hormonal

44

43.1

 

   Tamoxifen

23

22.5

 

   Aromatase

  
 

   inhibitor

17

16.7

 

   Both

2

2.0

 

   Unknown

2

2.0

 

Radiotherapy

74

72.5

 

Trastuzumab

3

2.9